|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||4.2500 - 4.2500|
|52 Week Range||2.5062 - 5.5500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group") is pleased to announce its interim results for the six months ended 30 June 2020. For the current period, the Group recorded a revenue of RMB12,590 million, an increase of 12.6% year-on-year, and profit attributable to shareholders of RMB2,314 million, an increase of 23.2% year-on-year. Basic earnings per share was RMB30.97 cents. The Board of Directors has declared an interim dividend of HK6 cents per share for 2020 and proposed a bonus issue.
Last week, you might have seen that CSPC Pharmaceutical Group Limited (HKG:1093) released its quarterly result to the...
Dividend paying stocks like CSPC Pharmaceutical Group Limited (HKG:1093) tend to be popular with investors, and for...